The effects of intravesical botulinum toxin A injections plus hydrodistention for neurogenic detrusor overactive

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022260

Enrollment

Unknown

Registered

2019-04-02

Start date

2019-03-25

Completion date

Unknown

Last updated

2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurological bladder

Interventions

experiment group:intravesical botulinum toxin A injections plus hydrodistention

control group:intravesical botulinum toxin A injections

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) at least 18 years old with various neurogenic disorders; (2) urodynamic DO with urinary incontinence; (3) an inadequate response or intolerance to oral anticholinergic drugs; (4) participants or their caregiver could perform clean intermittent catheterization (CIC).

Exclusion criteria

Exclusion criteria: (1) an allergy to BTX-A; (2) women were pregnant, lactating or planning to become pregnant during the course of the trial; (3) acute urinary tract infection.

Design outcomes

Primary

Measure	Time frame
maximum detrusor pressure (Pdetmax);	—

Countries

China

Contacts

Public ContactHUI CHEN

Guangdong Provincial Work Injury Rehabilitation Hospital

doc.chenhui@163.com+86 020-66600006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026